Comment on "Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma".
0/5 보강
APA
Qu L, Li R, Li Y (2025). Comment on "Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma".. Journal of the Formosan Medical Association = Taiwan yi zhi, 124(10), 998-999. https://doi.org/10.1016/j.jfma.2025.05.032
MLA
Qu L, et al.. "Comment on "Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma".." Journal of the Formosan Medical Association = Taiwan yi zhi, vol. 124, no. 10, 2025, pp. 998-999.
PMID
40436728 ↗
같은 제1저자의 인용 많은 논문 (5)
- Combined Blepharoplasty and Brow Fat Pad Transfer for the Correction of Dermatochalasis and Sunken Upper Eyelids.
- Successful Treatment With Neoadjuvant Chemo-Immunotherapy for Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Patient Report and Literature Review.
- Foundation Model-Enabled Multimodal Deep Learning for Prognostic Prediction in Colorectal Cancer with Incomplete Modalities: A Multi-Institutional Retrospective Study.
- Development and external validation of a prognostic nomogram for event-free survival in resectable non-small cell lung cancer after neoadjuvant chemoimmunotherapy.
- Comparison of Postoperative Scarring in Asian Women After Supra-brow and Sub-brow Blepharoplasty: A Retrospective Study.